Results 261 to 270 of about 4,877,549 (387)

Hypoxia‐Inducible Factor‐1 as a Therapeutic Target in Endometrial Cancer Management [PDF]

, 2010
Laura M S Seeber, Ronald P. Zweemer, René H.M. Verheijen, P. J. van Diest   +3 more
openalex   +1 more source

Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996‐2023: An Observational Study of the Welsh Population

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews, Arron Lacey, Kate Bache, Emma J. Kidd   +3 more
wiley   +1 more source

Targeting cuproptosis for treatment and prognostic assessment in endometrial cancer. [PDF]

Cancer Cell Int
Yu J, Shi H, Zhang J, Shan W, Xu Q, Shang H.   +5 more
europepmc   +1 more source

Gene signatures and prognostic factors in endometrial cancer. A study with special focus on vascular invasion

, 2011
Monica Mannelqvist
openalex   +1 more source

A single center retrospective study of molecular classification in endometrial cancer patients

Min Sun Kyoung, Seung Ho Kim, Hye Yon Cho   +2 more
openalex   +1 more source

What is currently known about endometrial cancer in Lynch syndrome? - review

, 2019
Agnieszka Kwiatkowska, Dominika Krawczyk, Krzysztof Kułak, Sylwester Makuch, Klaudia Sapko   +4 more
openalex   +2 more sources

Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen [PDF]

, 2017
Se Jeong Jeon, Jae Il Lee, Maria Lee, Hee Seung Kim, Jae‐Weon Kim, Noh Hyun Park, Yong Sang Song   +6 more
openalex   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel, Aureliane Pierret, Edouard G. Mills, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source

Exploring endometrial cancer in premenopausal women-A nationwide PremEnCa cohort study. [PDF]

Acta Obstet Gynecol Scand
Ioannou C, Malmsten C, Ehn P, Holmberg E, Dahm-Kähler P, Stålberg K.   +5 more
europepmc   +1 more source

Body Mass and the Risk of Endometrial Cancer

, 2010
Kristina Lindemann
openalex   +1 more source